홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

1,2-Dichloroethane → Biotin

HRID 1175643
인쇄

반응식

HRID 1175643 반응식
[CH2:1]1[S:5][C@@H:4]([CH2:6][CH2:7][CH2:8][CH2:9][C:10](NCCCCCC(NN)=O)=[O:11])[C@H:3]2[NH:22][C:23]([NH:25][C@@H:2]12)=[O:24].C(Cl)CCl.C1N(CCS(O)(=O)=O)CC[O:32]C1>CS(C)=O>[OH:32][C:10]([CH2:9][CH2:8][CH2:7][CH2:6][C@H:4]1[C@@H:3]2[C@@H:2]([NH:25][C:23]([NH:22]2)=[O:24])[CH2:1][S:5]1)=[O:11]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

5

반응물 3

HCID 111,2-DichloroethaneHCID 781654-Morpholineethanesulfonic acid2회HCID 83900Biotinamidocaproyl hydrazide

생성물 1

HCID 171548Biotin

시약·촉매·용매 1

HCID 679Dimethyl Sulfoxide용매

실험 절차

Natural GAGs (NAH, HS, HA, HEP, Ch, CS-A(S), CS-A(W), CS-B, CS-C, CS-D, CS-E, and KS) were dissolved in 0.1 M MES buffer (pH 5.5) to prepare 10 mg/ml GAG solutions. 25 μl of 20 mM biotin-LC-hydrazide (manufactured by Pierce Biotechnology) dissolved in dimethylsulfoxide (manufactured by Wako Pure Chemical Industries, Ltd.) was added to 1 ml of each GAG solution. Subsequently, 12.5 μl of a 100 mg/ml EDC (manufactured by Pierce Biotechnology) solution prepared with 0.1 M MES buffer (pH 5.5) was added thereto. The mixture was mixed well, and then allowed to react with stirring at normal temperature (15° C. to 25° C.) for 16 to 24 hours. After completion of the reaction, the reaction products were dialyzed by using a dialysis membrane (cutoff molecular weight: 10,000 or less) against phosphate buffered saline (pH 7.2 to 7.5, containing no divalent ions such as calcium ion: hereinafter, referred to as “PBS(−)”) as dialysis solution, to thereby sufficiently remove free biotin. After completion of dialysis, the concentration of Bi-GAG was adjusted to 5 mg/ml, followed by freeze preservation.

후처리

  1. customto prepare 10 mg/ml GAG solutions
  2. additionwas added to 1 ml of each GAG solution
  3. additionwas added
  4. additionThe mixture was mixed well
  5. customto react
  6. customAfter completion of the reaction
  7. customthe reaction products were dialyzed
  8. additioncontaining no divalent ions such as calcium ion
  9. customas dialysis solution
  10. customAfter completion of dialysis

출처 및 근거

ORD 기록
ord-e38685b3b95147df805acaeb5853a967
출처 데이터셋
uspto-grants-2010_11
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07842500B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트